ESR1 and breast cancer: We found that ESR2 mRNA is not abundantly expressed in primary breast cancer, but that higher ESR2 expression is found particularly within ERα-negative breast cancer subtypes and that ESR2-high has a significant association to survival in endocrine-treated patients as well as patients with TNBC.